{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:19:04Z","timestamp":1790857144977,"version":"4.1.0"},"reference-count":49,"publisher":"Microbiology Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"abstract":"<jats:p>The flavivirus tick-borne encephaltis virus (TBEV) was established as a vector system for heterologous gene expression. The variable region of the genomic 3\u2032 non-coding region was replaced by an expression cassette consisting of the reporter gene enhanced green fluorescent protein (EGFP) under the translational control of an internal ribosomal entry site element, both in the context of an infectious virus genome and of a replicon lacking the genes of the surface proteins prM\/M and E. The expression level and the stability of expression were measured by fluorescence-activated cell-sorting analysis and compared to an established alphavirus replicon vector derived from Venezuelan equine encephaltis virus (VEEV), expressing EGFP under the control of its natural subgenomic promoter. On the first day, the alphavirus replicon exhibited an approximately 180-fold higher expression level than the flavivirus replicon, but this difference decreased to about 20- and 10-fold on days 2 and 3, respectively. Four to six days post-transfection, foreign gene expression by the VEEV replicon vanished almost completely, due to extensive cell killing. In contrast, in the case of the TBEV replicon, the percentage of positive cells and the amount of EGFP expression exhibited only a moderate decline over a time period of almost 4\u2005weeks. The infectious TBEV vector expressed less EGFP than the TBEV replicon at all times. Significant expression from the infectious vector was maintained for four cell-culture passages. The results indicate that the VEEV vector is superior with respect to achieving high expression levels, but the TBEV system may be advantageous for applications that require a moderate, but more enduring, gene expression.<\/jats:p>","DOI":"10.1099\/vir.0.80677-0","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T22:43:13Z","timestamp":1111531393000},"page":"1045-1053","source":"Crossref","is-referenced-by-count":30,"title":["Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon"],"prefix":"10.1099","volume":"86","author":[{"given":"Rainer","family":"Gehrke","sequence":"first","affiliation":[{"name":"Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz X.","family":"Heinz","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Mandl","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1073\/pnas.95.22.12989","article-title":"Noncytopathic Sindbis virus RNA vectors for heterologous gene expression","volume":"95","author":"Agapov","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R2","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1128\/JVI.76.8.3791-3799.2002","article-title":"Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity","volume":"76","author":"Anraku","year":"2002","journal-title":"J Virol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1128\/JVI.74.22.10623-10630.2000","article-title":"Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles","volume":"74","author":"Balasuriya","year":"2000","journal-title":"J Virol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0264-410X(01)00485-6","article-title":"Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses","volume":"20","author":"Balasuriya","year":"2002","journal-title":"Vaccine"},{"key":"R5","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1128\/JVI.67.11.6439-6446.1993","article-title":"Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs","volume":"67","author":"Bredenbeek","year":"1993","journal-title":"J Virol"},{"key":"R6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(02)00558-3","article-title":"Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7","volume":"21","author":"Daemen","year":"2003","journal-title":"Vaccine"},{"key":"R7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/JVI.74.1.371-378.2000","article-title":"Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles","volume":"74","author":"Davis","year":"2000","journal-title":"J Virol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1128\/JVI.76.17.8966-8972.2002","article-title":"Genetically stable picornavirus expression vectors with recombinant internal ribosomal entry sites","volume":"76","author":"Dufresne","year":"2002","journal-title":"J Virol"},{"key":"R9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/JVI.68.3.1721-1727.1994","article-title":"Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells","volume":"68","author":"Frolov","year":"1994","journal-title":"J Virol"},{"key":"R10","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/JVI.73.5.3854-3865.1999","article-title":"Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells","volume":"73","author":"Frolov","year":"1999","journal-title":"J Virol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.77.16.8924-8933.2003","article-title":"Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line","volume":"77","author":"Gehrke","year":"2003","journal-title":"J Virol"},{"key":"R12","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1016\/S0264-410X(03)00307-4","article-title":"Evaluation of Venezuelan equine encephalitis (VEE) replicon-based outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease","volume":"21","author":"Gipson","year":"2003","journal-title":"Vaccine"},{"key":"R13","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1073\/pnas.1834270100","article-title":"DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus","volume":"100","author":"Hall","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1099\/vir.0.18738-0","article-title":"Construction and immunogenicity in a prime\u2013boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine","volume":"84","author":"Hanke","year":"2003","journal-title":"J Gen Virol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.77.14.7796-7803.2003","article-title":"Kunjin virus replicon vectors for human immunodeficiency virus vaccine development","volume":"77","author":"Harvey","year":"2003","journal-title":"J Virol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/JVI.78.1.531-538.2004","article-title":"Tetracycline-inducible packaging cell line for production of flavivirus replicon particles","volume":"78","author":"Harvey","year":"2004","journal-title":"J Virol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00705-003-0262-y","article-title":"Sub-genomic replicons of Tick-borne encephalitis virus","volume":"149","author":"Hayasaka","year":"2004","journal-title":"Arch Virol"},{"key":"R18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates","volume":"251","author":"Hevey","year":"1998","journal-title":"Virology"},{"key":"R19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1357-4310(99)01622-6","article-title":"RNA viruses: emerging vectors for vaccination and gene therapy","volume":"6","author":"Hewson","year":"2000","journal-title":"Mol Med Today"},{"key":"R20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/135502802317247776","article-title":"Expression of brain-derived neurotrophic factor in the central nervous system of mice using a poliovirus-based vector","volume":"8","author":"Jia","year":"2002","journal-title":"J Neurovirol"},{"key":"R21","first-page":"555","article-title":"Replicon-based vectors of positive strand RNA viruses","volume":"2","author":"Khromykh","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"R22","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.71.2.1497-1505.1997","article-title":"Subgenomic replicons of the flavivirus Kunjin: construction and applications","volume":"71","author":"Khromykh","year":"1997","journal-title":"J Virol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"11434","DOI":"10.1128\/JVI.76.22.11434-11439.2002","article-title":"Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic Sindbis virus vector","volume":"76","author":"Kong","year":"2002","journal-title":"J Virol"},{"key":"R24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.0269-283X.2004.00505.x","article-title":"Susceptibility of mosquito and tick cell lines to infection with various flaviviruses","volume":"18","author":"Lawrie","year":"2004","journal-title":"Med Vet Entomol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nbt1291-1356","article-title":"A new generation of animal cell expression vectors based on the Semliki Forest virus replicon","volume":"(N Y) 9","author":"Liljestr\u00f6m","year":"1991","journal-title":"Biotechnology"},{"key":"R26","first-page":"991","article-title":"Flaviviridae : the viruses and their replication","volume-title":"In Fields Virology","author":"Lindenbach","year":"2001"},{"key":"R27","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1128\/JVI.77.18.10004-10014.2003","article-title":"Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3\u2032 untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication","volume":"77","author":"Lo","year":"2003a","journal-title":"J Virol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.77.23.12901-12906.2003","article-title":"Potential high-throughput assay for screening inhibitors of West Nile virus replication","volume":"77","author":"Lo","year":"2003b","journal-title":"J Virol"},{"key":"R29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1566523013349039","article-title":"Alphavirus vectors for gene therapy applications","volume":"1","author":"Lundstrom","year":"2001","journal-title":"Curr Gene Ther"},{"key":"R30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14760584.2.3.445","article-title":"Alphavirus vectors for vaccine production and gene therapy","volume":"2","author":"Lundstrom","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"R31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/viro.1993.1247","article-title":"Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses","volume":"194","author":"Mandl","year":"1993","journal-title":"Virology"},{"key":"R32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1099\/0022-1317-78-5-1049","article-title":"Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr","volume":"78","author":"Mandl","year":"1997","journal-title":"J Gen Virol"},{"key":"R33","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/JVI.72.3.2132-2140.1998","article-title":"Spontaneous and engineered deletions in the 3\u2032 noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus","volume":"72","author":"Mandl","year":"1998","journal-title":"J Virol"},{"key":"R34","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1128\/JVI.77.2.1644-1648.2003","article-title":"Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins","volume":"77","author":"Molenkamp","year":"2003","journal-title":"J Virol"},{"key":"R35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2180-1-18","article-title":"Development of Dengue virus type 2 replicons capable of prolonged expression in host cells","volume":"1","author":"Pang","year":"2001","journal-title":"BMC Microbiol"},{"key":"R36","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1128\/JVI.74.20.9802-9807.2000","article-title":"Replicon vectors derived from Sindbis virus and Semliki Forest virus that establish persistent replication in host cells","volume":"74","author":"Perri","year":"2000","journal-title":"J Virol"},{"key":"R37","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1128\/JVI.77.19.10394-10403.2003","article-title":"An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector","volume":"77","author":"Perri","year":"2003","journal-title":"J Virol"},{"key":"R38","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1099\/0022-1317-78-7-1543","article-title":"Secondary structure of the 3\u2032-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development","volume":"78","author":"Proutski","year":"1997","journal-title":"J Gen Virol"},{"key":"R39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/JVI.78.2.1032-1038.2004","article-title":"High fidelity of yellow fever virus RNA polymerase","volume":"78","author":"Pugachev","year":"2004","journal-title":"J Virol"},{"key":"R40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"key":"R41","first-page":"779","article-title":"Secondary structure of the 3\u2032-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities","volume":"3","author":"Rauscher","year":"1997","journal-title":"RNA"},{"key":"R42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/14712598.1.2.177","article-title":"Alphavirus vectors: development and potential therapeutic applications","volume":"1","author":"Schlesinger","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"R43","doi-asserted-by":"crossref","first-page":"15607","DOI":"10.1073\/pnas.2136837100","article-title":"Use of Sindbis virus-mediated RNA interference to demonstrate a conserved role of Broad-Complex in insect metamorphosis","volume":"100","author":"Uhlirova","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/324581","article-title":"Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with Sindbis virus-based replicon particles","volume":"184","author":"Vajdy","year":"2001","journal-title":"J Infect Dis"},{"key":"R45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/viro.1998.9564","article-title":"Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes","volume":"255","author":"Varnavski","year":"1999","journal-title":"Virology"},{"key":"R46","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JVI.74.9.4394-4403.2000","article-title":"Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors","volume":"74","author":"Varnavski","year":"2000","journal-title":"J Virol"},{"key":"R47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/viro.1995.1557","article-title":"The flavivirus 3\u2032-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus","volume":"213","author":"Wallner","year":"1995","journal-title":"Virology"},{"key":"R48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-3527(03)59004-2","article-title":"Kunjin RNA replication and applications of Kunjin replicons","volume":"59","author":"Westaway","year":"2003","journal-title":"Adv Virus Res"},{"key":"R49","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1128\/JVI.77.11.6450-6465.2003","article-title":"Development and application of a reverse genetics system for Japanese encephalitis virus","volume":"77","author":"Yun","year":"2003","journal-title":"J Virol"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.80677-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T16:24:37Z","timestamp":1603383877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.80677-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.80677-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}